The United Nations has called an emergency meeting of animal disease experts amid fears African swine fever (ASF) is set to sweep through Asia and devastate pig farming.
Ten people on an Emirates airline flight were taken to a New York City hospital suffering flu-like symptoms, said New York City's acting health commissioner....
From BioPortfolio: NewsCompared with conventional vaccines, synthetic DNA vaccines can be manufactured faster and may avoid the need for annual vaccine reformulations.Contributed ...
Smokers at high risk of oral HPV and throat cancer Healthy Shoot A new study confirms smokers ar at higher risk of oral HPV infection, that causes throat can...
Vaccine Refrigerator Market To Exhibit Huge Growth On Account Of Rising Usage In Hospital, Blood Bank And Pharmacy Till 2022 | Million Insights September 05 08:33 2018 Million Insights – World’s Fastest Growing Market Research Database According to new report available with Million Insights, Vaccine Refrigerator is a refrigeration component designed precisely for storing vaccines and the other temperature-sensitive medical supplies, most of which need to be held at temperatures lower than that of a conventional fridge. Vaccine Refrigerator Market is categorized based on product type, applications, and geography. Global Vaccine Refrigerator Market is expected to grow at a significant CAGR in the upcoming years as the scope, product types and its applications are increasing across the globe. Vaccine Refrigerator is a refrigeration component designed precisely for storing vaccines and the other temperature-sensitive medical supplies, most of which need to be held at temperatures lower than that of a conventional fridge. The vaccine refrigerator unit offers constant low temperatures to avoid degradation of vaccines and other products. Additionally, the vaccine refrigerator also comes with options like backup power, alarms to provide complete protection. Furthermore, there are specifically designed vaccine refrigerators for storing biologics in an exclusive unit. Vaccine Refrigerator Market is categorized based on product type, applications, and geography. Full Research Report On Global Vaccine Refrigerator Market Analysis available at: https://www.millioninsights.com/industry-reports/vaccine-refrigerator-market Vaccine Refrigerator Industry is categorized based on product types such as Between 2°and 8°, Between 0°and -40°, Under -40°. Vaccine Refrigerator Market is categorized based on application into Hospital, Blood Bank, Pharmacy, Others. Vaccine Refrigerator Market is categorized based on geography into Asia Pacific (China, India, ASEAN, Australia & New Zealand), Japan, Middle East and Africa (GCC countries, S. Africa, Rest of MEA), North America (U.S., Canada), Latin America (Brazil, Rest of Latin America), Western Europe (Germany, Italy, France, England, Spain, Rest of Western Europe), and Eastern Europe (Poland, Russia, Rest of Eastern Europe). North America has been at the forefront with regards to Vaccine Refrigerator Industry and will continue to rule the roost in the years to come. Some of the key players that fuel the growth of the Vaccine Refrigerator Market include Panasonic, Dometic, Haier, SO-LOW, Helmer, Indrel, Follett, Thermo Fisher, Standex, Dulas, Migali Scientific, Felix Storch, SunDanzer, Sun Frost, Sure Chill, Woodley, Vestfrost Solutions. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour. Request for Free Sample Copy at:https://www.millioninsights.com/industry-reports/vaccine-refrigerator-market/request-sample Market Segment: Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vaccine Refrigerator in these regions, from 2012 to 2022 (forecast), covering • North America • Europe • China • Japan • Southeast Asia • India Global Vaccine Refrigerator market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including • Haier • Panasonic • Helmer • Follett • LEC • Thermo Fisher • Vestfrost Solutions • Felix Storch • KIRSCH • Meiling • Migali Scientific • Standex (ABS) • Fiocchetti • SO-LOW • Zhongke Duling • Aucma • Labcold • Tempstable • Indrel • Dulas On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into • Between 2° and 8° • Between 0°and -40° • Under -40° Related Reports of this Category available at Million Insights: https://www.millioninsights.com/industry/hospital-management On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Vaccine Refrigerator for each application, including • Hospital • Blood Bank • Pharmacy • Other About Million Insights Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive. For More Information: www.millioninsights.com Media Contact Company Name: Million Insights Contact Person: Ryan Manuel Email: Send Email Phone: 91-20-65300184 Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar City: Pune State: Maharashtra Country: India Website: www.millioninsights.com/industry-reports/vaccine-refrigerator-market Categories: Press Release
Quando si tratta di questioni di salute, è fondamentale sapere quali sono le farmacie buone e cattive. Devi imparare cosa cercare in una farmacia per sapere se è quella giusta. Ricorda, hai a che fare con la vita, ecco perché devi stare attento a dove acquistare i tuoi farmaci e altre necessità farmaceutiche.
Quando si tratta di questioni di salute, è fondamentale sapere quali sono le farmacie buone e cattive. Devi imparare cosa cercare in una farmacia per sapere se è quella giusta. Ricorda, hai a che fare con la vita, ecco perché devi stare attento a dove acquistare i tuoi farmaci e altre necessità farmaceutiche.
Quando si tratta di questioni di salute, è fondamentale sapere quali sono le farmacie buone e cattive. Devi imparare cosa cercare in una farmacia per sapere se è quella giusta. Ricorda, hai a che fare con la vita, ecco perché devi stare attento a dove acquistare i tuoi farmaci e altre necessità farmaceutiche.
Cross-sectional studies show a lower health-related quality of life (HRQoL) in individuals with narcolepsy. We aimed to describe changes in HRQoL after two years of multidisciplinary follow-up in a cohort of mainly post-H1N1 vaccination narcolepsy type-1 (NT1) patients in Norway.
Microbiologist Maurice R. Hilleman, arguably, saved more lives than any other doctor or medical researcher of the 20th century; during his 40-year career, he developed over 40 human and animal vaccines.
Objective To test the theoretical utility of incorporating nonavalent vaccination against HPV into a clinical setting. Methods The present retrospective study included data from consecutive patients who underwent HPV‐DNA testing between January 1, 1998, and December 31, 2015. Changes in the prevalence of different HPV types were assessed during three periods (T1, 1998–2003; T2, 2004–2009; and T3, 2010–2015) using XY analysis. Results The study included a total of 13 665 patients. Overall, 1361, 5130, and 7174 patients were included in the T1, T2, and T3 periods, respectively. The quadrivalent vaccine would have potentially protected against HPV in 71.5% (973/1361), 46.5% (2385/5130), and 26.5% (1901/7174) of patients in T1, T2, and T3, respectively (P<0.001 for trend). The nonavalent vaccine could have protected against HPV in 92.5% (1259/1361), 72.3% (3709/5130), and 58.1% (4168/7174) of patients in T1, T2, and T3, respectively (P<0.001 for trend). The proportion of patients with genital dysplasia grade 2+ who did not have infections with HPV genotypes covered by the quadrivalent or nonavalent vaccines increased across the three periods (P<0.001 for trend). For all study periods, the protection provided by the nonavalent vaccine would have been superior to the quadrivalent vaccine (χ2 test P<0.001). Conclusion The introduction of a nonavalent vaccine could improve protection against HPV infections and HPV‐related genital dysplasia.
A chickenpox-related stroke in a healthy 11-month-old boy serves as a scary reminder that the childhood disease is not as benign as some parents believe....
Researchers used computers to recreate a kind of simple protein catalyst--just a few amino acids long--that may have been around since the dawn of life.
Passengers and crew on two American Airlines flights arriving from Europe were held away from other travelers upon arrival in Philadelphia on Thursday after several showed signs of “flu-like symptoms,” federal officials said.
The nasal spray is back in the picture in newly-released flu vaccine recommendations from the American Academy of Pediatrics. But MUSC Children’s Health critical care specialist Elizabeth Mack said the nasal spray is still not the right choice for most.
Porcine circovirus 3 (PCV‐3) prevalence has been minimally investigated in wild boar; dynamics of infection and viral tissue distribution are currently unknown. In this study, serum samples from 518 wild boar (from years 2004 to 2018) were used to study frequency of infection. Also, serum samples from 19 boar captured and recaptured at least two times for a period of time from 1 month to 1 year were collected to determine PCV‐3 infection dynamics. Finally, to elucidate PCV‐3 DNA organic distribution, sera, different tissues and faeces were obtained from 35 additional wild boar. PCV‐3 DNA was extracted and amplified with a conventional PCR. For the PCV‐3 PCR‐positive sera from the longitudinally sampled and different tissue types, a quantitative PCR was performed. Genome sequence was obtained from a number of PCV‐3 PCR‐positive samples from different years, different time‐points of infection and tissues. Obtained results confirmed the susceptibility of wild boar to the virus, showing high frequency of PCV‐3 detection (221 out of 518, 42.66%) and demonstrating circulation at least since 2004. Compiled data indicate the possibility of long‐term infections, since 5 out of 10 PCV‐3 PCR‐positive boars longitudinally sampled showed positivity in samplings separated for more than 5 months. All tested tissue types’ harboured PCV‐3 genome, with the highest percentage of PCR positivity in submandibular lymph node, tonsil, lung, liver, spleen and kidney. The amount of DNA in all tested PCV‐3 PCR‐positive samples was moderate to low. All partial and complete PCV‐3 sequences obtained from wild boar displayed high nucleotide identity, higher than 98%. In conclusion, this study further confirms that wild boar is susceptible to PCV‐3 infection, showing high frequency of detection in this animal species. Furthermore, PCV‐3 can be found in different tissues of wild boar and is apparently able to cause persistent infection.
Emory University has now teamed with a pharmaceutical manufacturer to develop a therapeutic vaccine for human papillomavirus (HPV) infection, with a specific focus on head and neck cancers.
The suspense is tough. Will the HPV vaccine reduce cervical cancer and related deaths or won't it? It should, but this is a disease that takes so long to develop, there was never going to be a quick answer. In my previous post, I discussed the Cochrane systematic review and meta-analysis of HPV vaccine randomized trials (Arbyn 2018). The trials could test whether the vaccination reduces HPV infection and abnormal cervical cells - which sometimes progress to invasive cancer. But they aren't big or long enough to prove that this reduction translates into a lower rate of cervical cancer. Working out whether vaccination ultimately reduces cancer won't just take a long time: it won't be straightforward, either. I left the issue of tracking what's happening at that. But the conversation after my post convinced me I should dig into this, too. First, though, a quick recap on cervical cancer and terminology. This graphic maps out the complexity of HPV infection and
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.